Records View

Comparative analysis of the clinical effectiveness for capillary blood sampling in term newborns: laser lancing device versus automatic incision device. Randomized, Non-inferiority study.

Status Approved

  • First Submitted Date

    2020/03/30

  • Registered Date

    2020/04/08

  • Last Updated Date

    2021/10/18

CRIS Required

WHO ICTRP (International Clinical Trial Registry Platform) Required

  • 1. Background

    Background - CRIS Registration Number, Unique Protocol ID, Public/Brief Title, Scientific Title, Acronym, MFDS Regulated Study, IND/IDE Protocol, Registered at Other Registry, Name of Registry/Registration Number
    CRIS
    Registration Number
    KCT0004901
    Unique Protocol ID 2020AS0077
    Public/Brief Title Comparative analysis of the clinical effectiveness for capillary blood sampling in term newborns: laser lancing device versus automatic incision device.
    Scientific Title Comparative analysis of the clinical effectiveness for capillary blood sampling in term newborns: laser lancing device versus automatic incision device. Randomized, Non-inferiority study.
    Acronym
    MFDS Regulated Study No
    IND/IDE Protocol
    Registered at Other Registry No
    Healthcare Benefit Approval Status Not applicable
  • 2. Institutional Review Board / Ethics Committee

    Institutional Review Board Information
    Board Approval Status Submitted approval
    Board Approval Number 2020AS0077
    Approval Date 2020-03-24
    Institutional Review Board Name Korea University Ansan Hospital Institutional Review Board
    Institutional Review Board Address 123, Jeokgeum-ro, Danwon-gu, Ansan-si, Gyeonggi-do
    Institutional Review Board Telephone 031-412-6514
    Data Monitoring Committee
  • 3. Contact Details

    Contact Details Information - Contact Person for Principal Investigator / Scientific Queries, Contact Person for Public Queries, Contact Person for Updating Information의 Name, Title, Email, Telephone, Cellular Phone, Affiliation, Address
    Contact Person for Principal Investigator / Scientific Queries
    Name Byung Min Choi
    Title Professor
    Telephone +82-31-412-5551
    Affiliation Korea University Ansan Hospital
    Address 123, Jeokgeum-ro, Danwon-gu, Ansan-si, Gyeonggi-do, Republic of Korea
    Contact Person for Public Queries
    Name Eui Kyung Choi
    Title professor
    Telephone +82-31-412-5551
    Affiliation Korea University Ansan Hospital
    Address 123, Jeokgeum-ro, Danwon-gu, Ansan-si, Gyeonggi-do, Republic of Korea
    Contact Person for Updating Information
    Name Eui Kyung Choi
    Title professor
    Telephone +82-31-412-5551
    Affiliation Korea University Ansan Hospital
    Address 123, Jeokgeum-ro, Danwon-gu, Ansan-si, Gyeonggi-do, Republic of Korea
  • 4. Status

    Status Information - Study Site, Overall Recruitment Status, Date of First Enrollment, Status of First Enrollment, Target Number of Participant, Primary Completion Date, Recruitment Status by Participating Study Site, Name of Study Site, Recruitment Status, Date of First Enrollment, Status of First Enrollemnt
    Study Site Single
    Overall Recruitment Status Completed
    Date of First Enrollment 2020-06-09 Actual
    Target Number of Participant 42
    Primary Completion Date 2021-09-17 , Actual
    Study Completion Date 2021-09-17 , Actual
    Recruitment Status by Participating Study Site 1
    Name of Study Korea University Ansan Hospital
    Recruitment Status Completed
    Date of First Enrollment 2020-06-09 ,
  • 5. Source of Monetary / Material Support

    Source of Monetary / Material Support Information - Organization Name, Organization Type, Project ID
    1. Source of Monetary/Material Support
    Organization Name Korea University Ansan Hospital
    Organization Type Medical Institute
    Project ID
  • 6. Sponsor Organization

    Sponsor Organization Information - Organization Name, Organization Type
    1. Sponsor Organization
    Organization Name Korea University Ansan Hospital
    Organization Type Medical Institute
  • 7. Study Summary

    Study Summary Information
    Lay Summary
    When newborn babies for blood sampling, it is widely used because it is easier and safer to collect capillary blood by placing the heel of a newborn in a "heel puncture" rather than in an artery or vein. However, not only can the heel cause pain in newborns, but it can also be a new risk factor, such as bruises and infections.
    The automatic incision device is widely used in Korea instead of a manual lancet in the past. An automatic incision device that automatically moves the blade back and forth, designed to reduce pain by cutting the blood vessels in the upper part of the skin and not touching the pain nerve fibers that are located deep, and to facilitate extraction that is less affected by the nurse's proficiency than the passive needle's.
    Recently, laser lancet device (HandyRay ®) have been marketed in Korea after obtaining a KFDA license. This is reported to have the advantages of reducing the risk and pain of secondary infections and improving the healing process of wounds, compared to the needle or blade used to collect capillary blood from the fingers in adult diabetics.
    
    Aim of our study
    The clinical usefulness of laser lancet device (handyRay ®) for capillary blood collection in full-term newborn babies and automated incision device  are to be compared and analyzed. Therefore, we would compare and observe efficacy of blood collection, pain reactions and wound healing processes.
    
    Hypothesis
    There will be no difference in clinical usefulness between laser lancet device (handyRay ®) for capillary blood collection and automated incisional device.
  • 8. Study Design

    Study Design Information - Study Type, Study Purpose, Phase, Intervention Model, Blinding/Masking, Blinded Subject, Allocation, Intervention Type, Intervention Description, Number of Arms, Arm Label, Target Number of Participant, Arm Type, Arm Description
    Study Type Interventional Study
    Study Purpose
     Supportive Care
    Phase Not applicable
    Intervention Model Cross-over  
    Blinding/Masking Open
    Allocation RCT
    Intervention Type Medical Device  
    Intervention Description
    Groups A and B are randomly assigned to the infants who meet the selection criteria of this study before starting the study. Put notes from group A and group B in an invisible envelope and seal them so that they cannot be opened, and store them in random order. The envelopes are opened in order and assigned to groups A and B.
    
    Group A first uses laser lancet device to collect blood, and the next day, the same amount is collected using automatic incision device.The B group first uses automatic incision device to collect the same amount of blood the next day using laser lancet device.
    
    When using a laser lancet device, prepare by referring to the instructions for use. The laser adjustment phase (Level 1 through 5) is followedby the Level 2 for collecting blood. If sufficient amount of blood is not collected, repeat the puncture by Level 3. If sufficient amount is not collected, it is defined as failure.
    When using an automatic incision device, prepare by referring to the instructions for use. Among two types of BD Quikheel® Lancet (Infant for Preemie), start collecting blood for Infant type. If not enough blood is collected, it is defined as failure.
    
    Side effects of infant capillary blood collection typically include bleeding, pain, bruising, infection and discoloration both of which are at risk.
    Number of Arms 2
    Arm 1

    Arm Label

    B group

    Target Number of Participant

    42

    Arm Type

    Others

    Arm Description

    The B group first uses automatic incision device to collect the same amount of blood the next day using laser lancet device.
    
    
    When using an automatic incision device, prepare by referring to the instructions for use. Among two types of BD Quikheel® Lancet (Infant for Preemie), start collecting blood for Infant type. If not enough blood is collected, it is defined as failure.
    When using a laser lancet device, prepare by referring to the instructions for use. The laser adjustment phase (Level 1 through 5) is followed by the Level 2 for collecting blood. If sufficient amount of blood is not collected, repeat the puncture by Level 3. If sufficient amount is not collected, it is defined as failure.
    Arm 2

    Arm Label

    A group

    Target Number of Participant

    42

    Arm Type

    Others

    Arm Description

    Group A first uses laser lancet device to collect blood, and the next day, the same amount is collected using automatic incision device.
    
    When using a laser lancet device, prepare by referring to the instructions for use. The laser adjustment phase (Level 1 through 5) is followed by the Level 2 for collecting blood. If sufficient amount of blood is not collected, repeat the puncture by Level 3. If sufficient amount is not collected, it is defined as failure.
    When using an automatic incision device, prepare by referring to the instructions for use. Among two types of BD Quikheel® Lancet (Infant for Preemie), start collecting blood for Infant type. If not enough blood is collected, it is defined as failure.
  • 9. Subject Eligibility

    Subject Eligibility Information
    Condition(s)/Problem(s)    Not Applicable-Etc 

    Jaundice, Neonatal
    Rare Disease No
    Inclusion Criteria

    Gender

    Both

    Age

    1Day~6Month

    Description

    - Full term neonate admitted to Korea University Ansan Hospital.
    - When capillary blood gas analysis or bilirubin examination is required for more than two consecutive days
    - Clinical hemodynamic conditions have been identified to allow capillary blood to be collected with the heel sampling
    - If the parents of the study participants voluntarily sign the informed consent
    Exclusion Criteria
    - In case of an unstable hemodynamic condition, such as congenital heart disease or severe respiratory difficulty, which affects the time of capillary refill
    - If no blood test is required
    - Premature babies under 37 weeks of pregnancy
    Healthy Volunteers No
  • 10. Outcome Measure(s)

    Outcome Measure(s) Information - Type of Primary Outcome, Primary Outcome, Outcome, Timepoint, Secondary Outcome, Outcome, Timepoint
    Type of Primary Outcome /Safety/Efficacy
    Primary Outcome(s) 1
    Outcome
    Efficacy of blood sampling and pain score assesment
    Timepoint
    Immediate after procedure
    Secondary Outcome(s) 1
    Outcome
    The skin damage caused by sampling
    Timepoint
    every day after procedure
  • 11. Study Results and Publication

    Study Results and Publication Information - Result Registered, Final Enrollment Number, Number of Publication, Publications, Results Upload, Date of Posting Results, Protocol URL or File Upload, Brief Summary
    Result Registered No
  • 12. Sharing of Study Data(Deidentified Individual-Patient Data, IPD)

    Sharing of Study Data Information - Sharing Statement, Time of Sharing, Way of Sharing
    Sharing Statement Yes
    Time of Sharing 2021. 3
    Way of Sharing Available on Request
    (ekchoi03@korea.ac.kr)
화면 최상단으로 이동

TOP

BOTTOM

화면 최하단으로 이동